Conference Coverage

LARC uptake surged immediately after Trump’s election


 

REPORTING FROM ACOG 2018

Insertions of long-acting contraceptives more than doubled on one campus during the 8 weeks after President Donald Trump’s election, as compared with the same time period 1 year earlier, Aparna Sridhar, MD, reported.

Mr. Trump’s campaign promise to repeal and replace the Affordable Care Act in the first 100 days of his presidency sparked concern in many young women that they would lose access to copay-free contraception. Therefore, based on news reports and data released by insurer AthenaHealth that noted a 19% increase in IUD insertion nationally between October and December 2016, Dr. Sridhar and her colleagues at the University of California, Los Angeles, retrospectively reviewed data on students requesting insertion of a long-acting contraceptive (LARC) at the university’s student health center in the 2 months before and after the 2016 presidential election.

Dr. Aparna Sridhar
“We noted that our schedules were getting packed with IUD [insertions] and people were exclusively saying that they were getting it because they were concerned about a loss of insurance coverage for contraception,” Dr. Sridhar said at the annual meeting of the American College of Obstetricians and Gynecologists.

In the 8 weeks prior to the November election, the UCLA doctors inserted 53 LARCs, the majority of which were levonorgestrel-releasing intrauterine systems. In the 8 weeks after the election, that number jumped to 118 insertions, a 123% increase (P = .02), again with a preponderance of hormonal IUDs. There was no statistically significant difference in insertions in the same 2 time periods in 2015, said Dr. Sridhar, of the UCLA department of obstetrics and gynecology.

The investigators also looked at whether the increase they saw could be related to the common year-end practice of maximizing health insurance benefits and found a significant increase in LARC insertions from 2015 to 2016, she added.

She noted that the team continues to monitor LARC insertions to look for additional behavior patterns.

Dr. Sridhar disclosed no financial conflicts of interest related to her presentation.

SOURCE: Sridhar, A et al. ACOG poster presentation.

Recommended Reading

Contraceptive use appears low in teen girls on teratogenic medications
MDedge ObGyn
More savings available from generic oral contraceptives
MDedge ObGyn
Greater gynecological but not medical risks with hysteroscopic sterilization
MDedge ObGyn
Does hormonal contraception increase the risk of breast cancer?
MDedge ObGyn
Does immediate postpartum LNG-IUD insertion negatively affect breastfeeding outcomes?
MDedge ObGyn
Court: State cannot sue over religious exemption expansion
MDedge ObGyn
MDedge Daily News: Stem cells may reverse premature menopause
MDedge ObGyn
Efavirenz-based ART may hamper vaginal ring contraception
MDedge ObGyn
FDA orders new restrictions on sale, distribution of Essure
MDedge ObGyn
How does oral contraceptive use affect one’s risk of ovarian, endometrial, breast, and colorectal cancers?
MDedge ObGyn